We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

163 hedge funds and large institutions have $880M invested in Meridian Bioscience Inc in 2013 Q2 according to their latest regulatory filings, with 163 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

593% more call options, than puts

Call options by funds: $478K | Put options by funds: $69K

Holders
163
Holders Change
+163
Holders Change %
–
% of All Funds
5.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
163
Increased
–
Reduced
–
Closed
–
Calls
$478K
Puts
$69K
Net Calls
+$409K
Net Calls Change
+$409K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
1
Brown Capital Management
Maryland
$91.6M +$91.9M +4,261,451 New
Neuberger Berman Group
2
Neuberger Berman Group
New York
$90.5M +$90.7M +4,207,199 New
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$65.6M +$65.8M +3,050,875 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$54.4M +$54.5M +2,529,039 New
Bank of New York Mellon
5
Bank of New York Mellon
New York
$44.5M +$44.6M +2,068,237 New
BFA
6
BlackRock Fund Advisors
California
$42.5M +$42.6M +1,977,132 New
CPCM
7
Clifton Park Capital Management
Delaware
$34M +$34.1M +1,581,987 New
BTW
8
Boston Trust Walden
Massachusetts
$28.4M +$28.5M +1,322,322 New
DRZID
9
DePrince Race & Zollo Inc (DRZ)
Florida
$26M +$26M +1,207,869 New
BIT
10
BlackRock Institutional Trust
California
$25.9M +$26M +1,205,511 New
ACM
11
Atlanta Capital Management
Georgia
$23.5M +$23.6M +1,092,721 New
Invesco
12
Invesco
Georgia
$22.5M +$22.5M +1,045,048 New
State Street
13
State Street
Massachusetts
$17.7M +$17.8M +823,698 New
CI
14
Cincinnati Insurance
Ohio
$17.6M +$17.7M +820,000 New
CCA
15
Conestoga Capital Advisors
Pennsylvania
$17.5M +$17.5M +812,302 New
CFC
16
Cincinnati Financial Corp
Ohio
$16.8M +$16.8M +780,000 New
Northern Trust
17
Northern Trust
Illinois
$16.6M +$16.7M +773,479 New
New York State Common Retirement Fund
18
New York State Common Retirement Fund
New York
$16M +$16.1M +745,915 New
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$13.2M +$13.2M +613,097 New
DIA
20
Denver Investment Advisors
Colorado
$13.1M +$13.1M +607,383 New
CCM
21
Century Capital Management
Massachusetts
$12.4M +$12.5M +577,611 New
BA
22
Broadview Advisors
Wisconsin
$12.2M +$12.2M +566,435 New
Ameriprise
23
Ameriprise
Minnesota
$9.88M +$9.91M +459,638 New
RFC
24
Russell Frank Company
Washington
$9.66M +$9.68M +449,068 New
GKIM
25
GW&K Investment Management
Massachusetts
$8.44M +$8.47M +392,603 New
1
2 3 4 5

VIVO Hedge Fund Activity: Q2 2013 in Review

163 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q2 2013, worth a combined $880M.

Buyers outnumbered sellers: 163 funds opened new VIVO positions and 0 closed out — a net gain of 163 holders — while 0 added to existing stakes and 0 trimmed.

  • 163 institutional investors held Meridian Bioscience Inc (VIVO) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $880M of Meridian Bioscience Inc stock for Q2 2013.
  • 163 funds opened new Meridian Bioscience Inc positions in Q2 2013 and 0 closed out, a net change of +163 holders.

Based on aggregated 13F filings for Q2 2013.